Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapyMURPHY, Robert L; BERZINS, Baiba; ZALA, Carlos et al.AIDS (London). 2010, Vol 24, Num 6, pp 885-890, issn 0269-9370, 6 p.Article

Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial : A5005s, a Substudy of AIDS Clinical Trials Group Study 384DUBE, Michael P; PARKER, Robert A; MULLIGAN, Kathleen et al.Clinical infectious diseases. 2007, Vol 45, Num 1, pp 120-126, issn 1058-4838, 7 p.Article

Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expressionBELIAKOVA-BETHELL, Nadejda; JAIN, Sonia; DUBE, Michael P et al.Antiviral research. 2014, Vol 107, pp 42-49, issn 0166-3542, 8 p.Article

Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy―Naive HIV-1―Infected IndividualsBROWN, Todd T; YUN CHEN; CURRIER, Judith S et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 3, pp 323-330, issn 1525-4135, 8 p.Article

Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy : The ACTG (AIDS Clinical Trials Group) Study 5152sTORRIANI, Francesca J; KOMAROW, Lauren; SQUIRES, Kathleen et al.Journal of the American College of Cardiology. 2008, Vol 52, Num 7, pp 569-576, issn 0735-1097, 8 p.Article

No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir-Ritonavir in Healthy Subjects without HIV Infection : A Placebo-Controlled Trial. CommentaryDUBE, Michael P; CHANGYU SHEN; GREENWALD, Martha et al.Clinical infectious diseases. 2008, Vol 47, Num 4, pp 567-576, issn 1058-4838, 10 p.Article

The effect of long-term storage on measured plasma lactate concentrations and prospective lactate results from a multicenter trial of antiretroviral therapyDUBE, Michael P; KITCH, Douglas W; PARKER, Robert A et al.Clinical chemistry and laboratory medicine. 2005, Vol 43, Num 9, pp 947-952, issn 1434-6621, 6 p.Article

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS society-USA PanelSCHAMBELAN, Morris; BENSON, Constance A; POWDERLY, William G et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 3, pp 257-275, issn 1525-4135, 19 p.Article

Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function: A Randomized, Controlled TrialGUPTA, Samir K; DEMING MI; MOE, Sharon M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 64, Num 3, pp 279-283, issn 1525-4135, 5 p.Article

Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infectionSTEIN, James H; BROWN, Todd T; CURRIER, Judith S et al.AIDS (London). 2013, Vol 27, Num 6, pp 929-937, issn 0269-9370, 9 p.Article

Neither Proteinuria Nor Albuminuria Is Associated With Endothelial Dysfunction in HIV-Infected Patients Without Diabetes or HypertensionGUPTA, Samir K; CHANGYU SHEN; MATHER, Kieren J et al.The Journal of infectious diseases. 2011, Vol 204, Num 12, pp 1946-1950, issn 0022-1899, 5 p.Article

Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: a pilot studyGUPTA, Samir K; JOHNSON, Raymond M; MATHER, Kieren J et al.AIDS (London). 2010, Vol 24, Num 9, pp 1377-1380, issn 0269-9370, 4 p.Article

Relationship of Body Composition, Metabolic Status, Antiretroviral Use, and HIV Disease Factors to Endothelial Dysfunction in HIV-Infected SubjectsDUBE, Michael P; CHANGYU SHEN; MATHER, Kieren J et al.AIDS research and human retroviruses. 2010, Vol 26, Num 8, pp 847-854, issn 0889-2229, 8 p.Article

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy : Recommendations of the adult AIDS clinical trial group cardiovascular disease focus group : HIV/AIDSDUBE, Michael P; SPRECHER, Dennis; NEVIN, Thomas et al.Clinical infectious diseases. 2000, Vol 31, Num 5, pp 1216-1224, issn 1058-4838Article

Low Baseline CD4⁺ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy InitiationGRANT, Philip M; KITCH, Douglas; BROWN, Todd T et al.Clinical infectious diseases. 2013, Vol 57, Num 10, pp 1483-1488, issn 1058-4838, 6 p.Article

Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1―Infected Men Who Have Sex With MenGIANELLA, Sara; SMITH, Davey M; MORRIS, Sheldon R et al.Clinical infectious diseases. 2013, Vol 57, Num 3, pp 441-447, issn 1058-4838, 7 p.Article

Genetic analysis implicates resistin in HIV lipodystrophyRANADE, Koustubh; GEESE, William J; NOOR, Mustafa et al.AIDS (London). 2008, Vol 22, Num 13, pp 1561-1568, issn 0269-9370, 8 p.Article

Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate : a pilot studyGUPTA, Samir K; JOHNSON, Raymond M; SAHA, Chandan et al.AIDS (London). 2008, Vol 22, Num 5, pp 653-655, issn 0269-9370, 3 p.Article

The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons : results from a randomized trialGUPTA, Samir K; PARKER, Robert A; ROBBINS, Gregory K et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 10, pp 2237-2242, issn 0931-0509, 6 p.Article

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosidesDUBE, Michael P; PARKE, Robert A; SNYDER, Sally W et al.AIDS (London). 2005, Vol 19, Num 16, pp 1807-1818, issn 0269-9370, 12 p.Article

A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study TeamABERG, Judith A; WILLIAMS, Paige L; TUN LIU et al.The Journal of infectious diseases. 2003, Vol 187, Num 7, pp 1046-1052, issn 0022-1899, 7 p.Article

Metabolic effects of nandrolone decanoate and resistance training in men with HIVSATTLER, Fred R; SCHROEDER, E. Todd; DUBE, Michael P et al.American journal of physiology. Endocrinology and metabolism. 2002, Vol 46, Num 6, pp E1214-E1222, issn 0193-1849Article

A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapyHAUBRICH, Richard H; CURRIER, Judith S; MCCUTCHAN, J. Allen et al.Clinical infectious diseases. 2001, Vol 33, Num 7, pp 1060-1068, issn 1058-4838Article